|
CR&T Announces the David L. Johns Family Fellowship at Weill Cornell Medical College
July, 2008
NCI/NIH Budget Update
October, 2007
Leukemia: Who is at Risk?
October, 2007
New Drugs for Liver Cancer
June, 2007
CR&T Looks for Researchers…It Is Unique
June, 2007
Iron overload in Myelodysplastic Syndrome (MDS). Is there a rationale for treatment?
June, 2007
4th International Patient Symposium
March, 2007
4th International Congress on Myeloproliferative Diseases and Myelodysplastic Syndromes
March, 2007
Cancer Deaths On The Decline
January, 2007
JAK2 Mutation – How to turn it off?
January, 2007
Future Treatments for CML
December, 2006
CALGB – 50 Years of Cancer Research
September, 2006
New Drug Approved for Leukemia
July,2006
Criteria Established for Treatment of MMM
June,2006
FDA Approves New Treatment for Myelodysplastic Syndromes (MDS)
May 3,2006
Breast-Cancer Drug Gains Traction
May 2,2006
Initial Results of the Study of Tamoxifen and Raloxifene
March 2006
FDA Approves Pfizer Drug for Two Cancers
January 2006
Resource News
January 2006
Revlimid® Approved by the FDA
January 2006
President Signs Cord Blood Stem Cell Bill
December 2005
And the number one cancer myth is...
June 2005
Researchers Show How Leukemia Develops After Cancer Treatment
May 2005
JAK2 Gene Produces Too Many Blood Cells - Confirmed
May 2005
Study: Young cancer patients bounce back
February 2005
Race for the Cure: The Role of the New York Phase II Consortium
January 2005
Report: Cancer rates down, survival up
June 2004
Although Recommended, G-CSF After Marrow Transplant May Raise
Graft-Versus-Host Disease Risk
March 2004
Gleevec Prolongs Life
December 2003
CR&T awards grant to Johns Hopkins group
for studies of polycythemia vera
April 2003
Polycythemia Vera: Gleevec may be effective against second blood disease
January 2003
Novartis Pharmaceuticals: New drug significantly improves survival even for
patients with late-stage disease
January 2003
Dr. Silver and members of CR&T medical board present findings at national
hematology meeting
December 2002
Antiangiogenics May Hold Promise for Leukemia
November 2002
Erasing signs of leukemia
Drug promising, but it may not help all patients
May 2002
Leukemia and Myeloproliferative Diseases Center to Be Established with Grant
from Cancer Research and Treatment Fund (Cornell University)
March 2002
Dr. Scott Wadler Named to Silver Professorship
February 2002
Gleevec: Mixed Opinions Now After Initial Enthusiasm
December 2001
Scientists Link Tumors To Bone Marrow Cells
November 2001
Dr. Silver receives Timothy Gee award
May 2001
New AmmunitionIn Cancer War Wonder drugs disarm proteins,with minimal
side effects (New York Daily News)
May 20, 2001, New York
Dr. Richard Silver's speech at 2001 Hall of Fame Dinner
April 2001, New York
Dr. Coleman Receives Award from Lymphoma Organization
March 2001, New York
For additional information, please contact:
Cancer Research & Treatment Fund
500 East 77th Street
Suite 1001
New York, NY 10162
Phone: 212-288-6604
Fax: 212-288-7704 or 212-746-8246
e-mail: director@crt.org
Back to top
|